Literature DB >> 17710065

Delayed colonic perforation after percutaneous radiofrequency ablation of hepatocellular carcinoma.

Yuk Pang Yeung1, Joseph Hui, Wai Chun Andrew Yip.   

Abstract

Radiofrequency ablation (RFA) is an effective treatment for hepatocellular carcinoma. Colonic perforation secondary to RFA of the liver is an uncommon complication that has been reported to have an incidence between 0.1% and 0.3%. Lesions adjacent (within 1 cm) to the colonic wall and those in patients with history of upper abdominal surgery or chronic cholecystitis are particularly at risk. More importantly, thermal injury leading to colonic perforation has proved to have a fatal outcome. We present a case of percutaneous RFA in a patient with hepatocellular carcinoma that was abutting the colonic hepatic flexure. Colonic perforation was diagnosed on the eighth day postablation when the patient was readmitted with peritonitis.

Entities:  

Mesh:

Year:  2007        PMID: 17710065     DOI: 10.1097/SLE.0b013e31805f704e

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  4 in total

1.  Radiofrequency ablation of a solitary liver metastasis complicated by colonic perforation.

Authors:  Alexander W Korutz; Kent T Sato
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

2.  A case of gouty arthritis following percutaneous radiofrequency ablation for hepatocellular carcinoma.

Authors:  Dae Hee Choi; Hyo-Suk Lee
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

3.  Case report: bowel perforation after cutaneous nerve radiofrequency ablation for postherniorrhaphy neuralgia.

Authors:  Steven A Neubauer; Nicholas B Capal; Sean C Reimer
Journal:  J Surg Case Rep       Date:  2022-07-07

4.  Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm).

Authors:  Byung Gon Na; Jong Man Kim; Dong Kyu Oh; Kyo-Won Lee; Tae-Wook Kang; Gyu-Seong Choi; Min Woo Lee; Choon Hyuck David Kwon; Hyun Chul Lim; Jae-Won Joh
Journal:  Ann Surg Treat Res       Date:  2017-04-27       Impact factor: 1.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.